Marlex ships first order to US Department of Defense
Last week the company initially announced the 8-year government distribution contract with the Office of Health Affairs (OHA), a branch of the US. Department of Homeland Security has
The US Food and Drug Administration (FDA) has approved AstraZeneca’s Imfinzi (durvalumab) in combination with Padcev (enfortumab vedotin) for adult patients with muscle-invasive bladder cancer (MIBC) who cannot receive or have refused cisplatin-based chemotherapy.
The agreement will leverage the enzyme platform technologies, services and expertise for the manufacturing of active pharmaceutical ingredients. DSM Pharmaceutical Products CEO Alexander Wessels said, "Via this agreement,
Afrezza is an investigational, ultra rapid-acting mealtime insulin therapy, administered using MannKind’s to-be-marketed next-generation inhaler. MannKind chairman and chief executive officer Alfred Mann said the completion of the
The collaboration targets the clinical activity and side-effect profile of the study drugs. The pancreatic cancer and breast cancer are the first target clinical indications under consideration. Immunovative